Form 4: TD SYNNEX Director Sells 5,000 Shares Under 10b5-1 Plan

TD SYNNEX Director Richard T. Hume sold 5,000 shares of common stock for approximately $760,598 on December 1, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Richard T. Hume, a Director of TD SYNNEX CORP (SNX), reported the sale of 5,000 shares of common stock.
• The sales occurred on December 1, 2025.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hume on July 14, 2025.
• The first block of 2,438 shares was sold at a weighted average price of $151.72 per share.
• The second block of 2,562 shares was sold at a weighted average price of $152.48 per share.
• Following these transactions, Mr. Hume beneficially owns 52,515 shares of TD SYNNEX common stock.
• The total value of shares sold is approximately $760,598.32.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be perceived negatively, the transaction was pre-planned under a 10b5-1 plan, which mitigates the negative signal. It's a routine disclosure of a director managing personal holdings.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment rather than an immediate reaction to new information.

Negatives

• A director selling a significant number of shares (5,000 shares) could be perceived negatively by investors, potentially signaling a lack of confidence, even if pre-planned.

Risks

• Investor perception of insider selling, even under a 10b5-1 plan, can sometimes lead to negative sentiment or speculation about the company's future prospects.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider's equity transaction.

Industry Context

Insider sales, even under 10b5-1 plans, are common across industries as executives manage personal finances and diversify portfolios. This specific transaction by a director of a major IT distributor like TD SYNNEX is a routine disclosure and does not inherently indicate broader industry trends or competitive shifts.

Stakeholder Impact

• Shareholders: May observe the director's sale and potentially interpret it as a signal, though the 10b5-1 plan context reduces its significance.

Key Dates

Recommendation

The filing reports a routine, pre-planned sale of shares by a director under a Rule 10b5-1 plan. This type of transaction is typically for personal financial management and diversification, rather than a reflection of new material information about the company's prospects. While insider selling can sometimes be a negative signal, the pre-arranged nature mitigates this concern. There is no new information in this filing to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

TD SYNNEX, SNX, Form 4, Insider Trading, Stock Sale, Director, Richard T. Hume, 10b5-1 Plan, Equity Transaction